Litigation Details for BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)

BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)

Docket		Date Filed	2015-03-06
Court	District Court, D. New Jersey	Date Terminated	2017-04-18
Cause	35:271 Patent Infringement	Assigned To	Michael Andre Shipp
Jury Demand	None	Referred To	Tonianne J. Bongiovanni
Parties	MERCK & CIE
Patents	7,566,462; 7,566,714; 7,612,073; 7,727,987; 7,947,681; 8,003,126; 8,067,416; 8,318,745; RE43,797
Attorneys	CHARLES MICHAEL LIZZA
Link to Docket	External link to docket

Details for BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-03-05	1		expiration of U.S. Patent Nos. 7,566,462 (“the ’462 patent”), 7,566,714 (“the ’714 patent”), 7,612,073 (“…(“the ’073 patent”), 7,727,987 (“the ’987 patent”), 8,003,126 (“the ’126 patent”), 8,067,416 (“the ’416…’416 patent”), RE43,797 (“the ’797 patent”), and 8,318,745 (“the ’745 patent”) (collectively, the “patents-in-suit…Okhamafe. The ’797 patent is a reissue of U.S. Patent No. 7,947,681. A copy of the ’797 patent is attached … 1. This is an action for patent infringement under the patent laws of the United States, Title	External link to document
2015-03-31	12		States Patent No. 7,566,462 (“the ’462 patent”); U.S. Patent No. 7,566,714 (“the ’714 patent”); U.S.…expiration of U.S. Patent Nos. 7,566,462 (“the ’462 patent”), 7,566,714 (“the ’714 patent”), 7,612,073 (…U.S. Patent No. 7,612,073 (“the ’073 patent”); U.S. Patent No. 7,727,987 (“the ’987 patent”); U.S. Patent…,126 (“the ’126 patent”); U.S. Patent No. 8,067,416 (“the ’416 patent”); U.S. Patent No. RE 43,797 (…the ’797 patent); and U.S. Patent No. 8,318,745 (“the ’745 patent”) (collectively, “the Patents-in-Suit	External link to document